Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction.

Brener SJ, Cristea E, Lansky AJ, Fahy M, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2012 Aug 1;5(4):563-9. doi: 10.1161/CIRCINTERVENTIONS.112.969022. Epub 2012 Jul 24.

2.

Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).

Brener SJ, Mehran R, Brodie BR, Guagliumi G, Witzenbichler B, Cristea E, Xu K, Lansky AJ, Stone GW.

Am J Cardiol. 2011 Oct 1;108(7):918-23. doi: 10.1016/j.amjcard.2011.05.022. Epub 2011 Jul 20.

PMID:
21764028
3.
4.

Is the myocardial blush grade scored by the operator during primary percutaneous coronary intervention of prognostic value in patients with ST-elevation myocardial infarction in routine clinical practice?

Kampinga MA, Nijsten MW, Gu YL, Dijk WA, de Smet BJ, van den Heuvel AF, Tan ES, Zijlstra F.

Circ Cardiovasc Interv. 2010 Jun 1;3(3):216-23. doi: 10.1161/CIRCINTERVENTIONS.109.916247. Epub 2010 May 4.

5.

Impact of thrombus aspiration use and direct stenting on final myocardial blush score in patients presenting with ST-elevation myocardial infarction.

Lemesle G, Sudre A, Bouallal R, Delhaye C, Rosey G, Bauters C, Lablanche JM.

Cardiovasc Revasc Med. 2010 Jul-Sep;11(3):149-54. doi: 10.1016/j.carrev.2010.03.080.

PMID:
20599164
6.

Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.

Brener SJ, Westerhout CM, Fu Y, Todaro TG, Moliterno DJ, Wagner GS, Granger CB, Armstrong PW; APEX-AMI Investigators.

Am Heart J. 2009 Nov;158(5):755-60. doi: 10.1016/j.ahj.2009.09.009. Epub 2009 Oct 3.

PMID:
19853693
7.

Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).

Nikolsky E, Mehran R, Yu J, Witzenbichler B, Brodie BR, Kornowski R, Brener S, Xu K, Dangas GD, Stone GW.

Am J Cardiol. 2013 May 15;111(10):1377-86. doi: 10.1016/j.amjcard.2013.01.285. Epub 2013 Mar 12.

PMID:
23465098
8.

Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.

Jarai R, Huber K, Bogaerts K, Droogne W, Ezekowitz J, Granger CB, Sinnaeve PR, Ross AM, Zeymer U, Armstrong PW, Van de Werf FJ; ASSENT IV-PCI investigators.

Am Heart J. 2010 Jan;159(1):131-40. doi: 10.1016/j.ahj.2009.11.001.

PMID:
20102879
9.
10.

Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.

Kalińczuk Ł, Przyłuski J, Karcz M, Petryka J, Kaczmarska E, Bekta P, Kepka C, Kruk M, Pregowski J, Kadziela J, Deptuch T, Skwarek M, Cedro K, Ciszewski M, Debski A, Ciszewski A, Chmielak Z, Demkow M, Witkowski A, Ruzyłło W.

Kardiol Pol. 2007 Jan;65(1):1-10; discussion 11-2. English, Polish.

11.

Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention.

Mehta RH, Harjai KJ, Cox D, Stone GW, Brodie B, Boura J, O'Neill W, Grines CL; Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.

J Am Coll Cardiol. 2003 Nov 19;42(10):1739-46.

12.

Impact of infarct-related artery patency before primary PCI on outcome in patients with ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.

Rakowski T, Dudek D, Dziewierz A, Yu J, Witzenbichler B, Guagliumi G, Kornowski R, Hartmann F, Lansky AJ, Brener SJ, Mehran R, Stone GW.

EuroIntervention. 2013 Mar;8(11):1307-14. doi: 10.4244/EIJV8I11A199.

13.

Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.

Stone SG, Serrao GW, Mehran R, Tomey MI, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Brener SJ, Dangas G, Stone GW.

Circ Cardiovasc Interv. 2014 Aug;7(4):543-51. doi: 10.1161/CIRCINTERVENTIONS.114.001360. Epub 2014 Jun 17.

14.

Mean platelet volume is associated with poor postinterventional myocardial blush grade in patients with ST-segment elevation myocardial infarction.

Sarli B, Baktir AO, Saglam H, Arinc H, Kurtul S, Sivgin S, Akpek M, Kaya MG.

Coron Artery Dis. 2013 Jun;24(4):285-9. doi: 10.1097/MCA.0b013e328360eff6.

PMID:
23542159
15.

Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.

Farkouh ME, Reiffel J, Dressler O, Nikolsky E, Parise H, Cristea E, Baran DA, Dizon J, Merab JP, Lansky AJ, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2013 Jun;6(3):216-23. doi: 10.1161/CIRCINTERVENTIONS.112.000142. Epub 2013 May 7.

16.

Reperfusion after primary angioplasty for ST-elevation myocardial infarction: predictors of success and relationship to clinical outcomes in the APEX-AMI angiographic study.

Brener SJ, Moliterno DJ, Aylward PE, van't Hof AW, Ruźyllo W, O'Neill WW, Hamm CW, Westerhout CM, Granger CB, Armstrong PW; APEX-AMI Investigators.

Eur Heart J. 2008 May;29(9):1127-35. doi: 10.1093/eurheartj/ehn125. Epub 2008 Mar 27.

17.

Predictors and impact of target vessel revascularization after stent implantation for acute ST-segment elevation myocardial infarction: lessons from HORIZONS-AMI.

Brener SJ, Ertelt K, Mehran R, Genereux P, Xu K, Witzenbichler B, Brodie BR, Guagliumi G, Stone GW.

Am Heart J. 2015 Feb;169(2):242-8. doi: 10.1016/j.ahj.2014.11.005. Epub 2014 Nov 12.

PMID:
25641533
18.

Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial.

Brener SJ, Dizon JM, Mehran R, Guerchicoff A, Lansky AJ, Farkouh M, Brodie B, Guagliumi G, Witzenbichler B, Fahy M, Parise H, Stone GW.

Am Heart J. 2013 Oct;166(4):676-83. doi: 10.1016/j.ahj.2013.07.025. Epub 2013 Sep 13.

PMID:
24093847
19.

Impact of nonculprit vessel myocardial perfusion on outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes: analysis from the ACUITY trial (Acute Catheterization and Urgent Intervention Triage Strategy).

Lansky AJ, Ng VG, Meller S, Xu K, Fahy M, Feit F, Ohman EM, White HD, Mehran R, Bertrand ME, Desmet W, Hamon M, Stone GW.

JACC Cardiovasc Interv. 2014 Mar;7(3):266-75. doi: 10.1016/j.jcin.2013.08.016.

20.

Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.

Brener SJ, Maehara A, Dizon JM, Fahy M, Witzenbichler B, Parise H, El-Omar M, Dambrink JH, Mehran R, Oldroyd K, Gibson CM, Stone GW.

JACC Cardiovasc Interv. 2013 Jul;6(7):718-24. doi: 10.1016/j.jcin.2013.03.013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk